Literature DB >> 16492837

Ultrasonic rat vocalizations during the formalin test: a measure of the affective dimension of pain?

Alexandre R Oliveira1, Helena M T Barros.   

Abstract

The emission of ultrasonic vocalization (USV) by rats submitted to the formalin test has not yet been demonstrated. We performed two experiments to establish the formalin concentration to induce USV and the relationship of USV emission with motor behaviors and the effects of morphine and naloxone on USV during the formalin test. Male Wistar rats were used. In Experiment 1, 3 different groups of rats were subcutaneously injected with 5%, 10%, or 12.5% formalin in 1 of the anterior paws. Experiment 2 was intended to verify the effect of morphine 1, 2.5, or 5 mg/kg on USV during the 12.5% formalin test, whereas other groups of rats received naloxone 2 mg/kg with each one of the morphine doses to verify the specificity of opioid action. USV and motor behaviors were simultaneously measured in 5-min windows for 40 min, and early (0-5 min), interphase (5-20 min), and late (20-40 min) phases of the test were characterized. Vocalization was detected mostly during the interphase of the formalin test, mainly after formalin 12.5%. Morphine suppressed USV in a naloxone-reversible manner. This is a demonstration of USV during the formalin test, allowing the inclusion of an additional nonreflex behavioral measure to help characterize more clinically relevant integrated behavioral patterns in this rat model of pain.

Entities:  

Mesh:

Year:  2006        PMID: 16492837     DOI: 10.1213/01.ane.0000196530.72813.d9

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  15 in total

Review 1.  Behavioral assessments of the aversive quality of pain in animals.

Authors:  Xu-Jie Zhang; Tian-Wei Zhang; San-Jue Hu; Hui Xu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.

Authors:  Enza Palazzo; Yu Fu; Guangchen Ji; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

4.  An improved behavioural assay demonstrates that ultrasound vocalizations constitute a reliable indicator of chronic cancer pain and neuropathic pain.

Authors:  Martina Kurejova; Ulrike Nattenmüller; Ullrich Hildebrandt; Deepitha Selvaraj; Sebastian Stösser; Rohini Kuner
Journal:  Mol Pain       Date:  2010-03-26       Impact factor: 3.395

Review 5.  Assessments of sensory plasticity after spinal cord injury across species.

Authors:  Jenny Haefeli; J Russell Huie; Kazuhito Morioka; Adam R Ferguson
Journal:  Neurosci Lett       Date:  2016-12-19       Impact factor: 3.046

6.  Efficacy of Common Analgesics for Postsurgical Pain in Rats.

Authors:  Megan E Waite; Ashleigh Tomkovich; Tammie L Quinn; Alan P Schumann; L Savannah Dewberry; Stacie K Totsch; Robert E Sorge
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

Review 7.  Preclinical Assessment of Inflammatory Pain.

Authors:  Milind M Muley; Eugene Krustev; Jason J McDougall
Journal:  CNS Neurosci Ther       Date:  2015-12-10       Impact factor: 5.243

8.  Profound swim stress-induced analgesia with ketamine.

Authors:  Asma Hayati Ahmad; Zalina Ismail; Myo Than; Azhar Ahmad
Journal:  Malays J Med Sci       Date:  2008-01

9.  Synergistic analgesia of duloxetine and celecoxib in the mouse formalin test: a combination analysis.

Authors:  Yong-Hai Sun; Yu-Lin Dong; Yu-Tong Wang; Guo-Li Zhao; Gui-Jun Lu; Jing Yang; Sheng-Xi Wu; Ze-Xu Gu; Wen Wang
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 10.  Biological Functions of Rat Ultrasonic Vocalizations, Arousal Mechanisms, and Call Initiation.

Authors:  Stefan M Brudzynski
Journal:  Brain Sci       Date:  2021-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.